CLEVELAND –The hybrid closed-loop insulin delivery system was at the top of Cleveland Clinic’s list of the Top 10 Medical Innovations of 2018.
The recently released list of up-and-coming technologies is selected each year by a panel of Cleveland Clinic physicians and scientists.
Hailed as the world’s first artificial pancreas, the hybrid closed-loop insulin delivery system for people with Type 1 diabetes enables direct communication between a continuous glucose monitoring device and insulin pump to stabilize blood glucose at an unprecedented level. The technology replaces the “open loop” concept that requires a patient to use information from their continuous glucose monitor to determine how much insulin to inject.
Experts are optimistic that the outcomes demonstrated in Type 1 diabetes will accelerate a similar product for Type 2 diabetes patients in the near future.
Also making this list was the emergence of telehealth, with the panel saying that extending the health care environment to a patient’s home has been a goal for decades. They said that due to an increase in connectivity through mobile technology and consumer demand, hospitals are getting ready for widespread adoption in 2018.
The centralized monitoring of hospital patients also made the list. This “mission control” operation incorporates off-site personnel using advanced equipment, including sensors and high-definition cameras, to monitor blood pressure, heart rate, respiration, pulse oximetry and more.
Other medical innovations making the list include neuromodulation to treat obstructive sleep apnea; gene therapy for inherited retinal diseases; and scalp cooling for reducing chemotherapy hair loss.